세계의 폴리에틸렌 글리콜 시장 : 등급, 용도, 분자량, 원료, 최종사용자 산업, 지역별 예측(-2032년)

Global Polyethylene Glycol Market Research Report By Grade (Pharmaceutical Grade, Industrial Grade, Cosmetic Grade, Food Grade), By Application (Pharmaceuticals, Cosmetics and Personal Care, Food and Beverages, Industrial Solvents, Textile Finishing), By Molecular Weight (200-400 g/mol, 400-600 g/mol, 600-1000 g/mol, 1000-2000 g/mol, Above 2000 g/mol), By Source (Ethylene Oxide, Ethylene Dichloride, Ethylene Glycol), By End-Use Industry (Medical Device, Pharmaceutical Packaging, Lubricant Additive, Paper Coating) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) Forecast to 2032

Overview of the Market

The Polyethylene Glycol Market's annual growth rate (CAGR) is anticipated to be approximately 6.55% over the course of the forecast period, according to MRFR analysis.

The growing need for medicines, personal care items, and industrial applications is expected to propel the polyethylene glycol market's expansion. The growing population and the rising incidence of chronic illnesses are major factors propelling the industry and raising demand for pharmaceuticals.

Furthermore, the demand for personal care goods is being fueled by emerging economies' growing disposable income. Technological developments in the manufacturing of polyethylene glycol have led to increased purity and better qualities in recent years. Furthermore, new prospects for market expansion are being created by the food and beverage industry's growing use of polyethylene glycol.

The pharmaceutical industry uses polyethylene glycol (PEG), a flexible polymer, extensively as an excipient in medicinal compositions. Injectables, oral drugs, and topical formulations are just a few of the pharmaceutical products that use PEG as a stabilizer, solubilizer, and viscosity modifier. The rising incidence of chronic illnesses like diabetes and cancer, which call for long-term therapy with PEG-based drugs, is fueling the pharmaceutical industry's expanding need for PEG.

Perspectives on Market Segments

Pharmaceutical, industrial, cosmetic, and food grades are the divisions of the global polyethylene glycol (PEG) market.

Pharmaceuticals, Cosmetics and Personal Care, Food and Beverages, Industrial Solvents, and Textile Finishing are the market's application-based divisions.

Five molecular weight ranges are used to segment the polyethylene glycol market: 200-400 g/mol, 400-600 g/mol, 600-1000 g/mol, 1000-2000 g/mol, and over 2000 g/mol. Every segment has its own growth patterns and serves end-use industries.

The market is divided into three segments based on the source: ethylene glycol, ethylene dichloride, and ethylene oxide.

The Polyethylene Glycol Market's revenue, segmentation, data, statistics, and industry growth are significantly influenced by the end-use industry segment.

Regional Perspectives

Understanding the dynamics and future potential of the polyethylene glycol market depends heavily on its regional segmentation. The main geographies examined in this research are North America, Europe, APAC, South America, and MEA. With over 35% of the Polyethylene Glycol Market's revenue in 2023, North America accounted for the highest market share. The demand for polyethylene glycol is driven by the region's robust personal care and pharmaceutical industries. Because of the existence of large chemical and pharmaceutical businesses, Europe has a huge market share that is second only to North America. According to projections, PAC will increase at the fastest rate till 2032.

Key Players

ExxonMobil, LyondellBasell Industries Holdings B.V., LG Chem, Formosa Plastics Corporation, Huntsman Corporation, Ineos Group Limited, Dow Chemical Company, Mitsubishi Chemical Holdings Corporation, China National Chemical Corporation, SABIC, Sinopec Group, Braskem, Celanese Corporation, and BASF are important players in the polyethylene glycol market.

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

• 1.1. MARKET OVERVIEW
• 1.2. KEY FINDINGS
• 1.3. MARKET SEGMENTATION
• 1.4. COMPETITIVE LANDSCAPE
• 1.5. CHALLENGES AND OPPORTUNITIES
• 1.6. FUTURE OUTLOOK

2. MARKET INTRODUCTION

• 2.1. DEFINITION
• 2.2. SCOPE OF THE STUDY
  • 2.2.1. RESEARCH OBJECTIVE
  • 2.2.2. ASSUMPTION
  • 2.2.3. LIMITATIONS

3. RESEARCH METHODOLOGY

• 3.1. OVERVIEW
• 3.2. DATA MINING
• 3.3. SECONDARY RESEARCH
• 3.4. PRIMARY RESEARCH
  • 3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • 3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5. FORECASTING MODEL
• 3.6. MARKET SIZE ESTIMATION
  • 3.6.1. BOTTOM-UP APPROACH
  • 3.6.2. TOP-DOWN APPROACH
• 3.7. DATA TRIANGULATION
• 3.8. VALIDATION

4. MARKET DYNAMICS

• 4.1. OVERVIEW
• 4.2. DRIVERS
• 4.3. RESTRAINTS
• 4.4. OPPORTUNITIES

5. MARKET FACTOR ANALYSIS

• 5.1. VALUE CHAIN ANALYSIS
• 5.2. PORTER'S FIVE FORCES ANALYSIS
  • 5.2.1. BARGAINING POWER OF SUPPLIERS
  • 5.2.2. BARGAINING POWER OF BUYERS
  • 5.2.3. THREAT OF NEW ENTRANTS
  • 5.2.4. THREAT OF SUBSTITUTES
  • 5.2.5. INTENSITY OF RIVALRY
• 5.3. COVID-19 IMPACT ANALYSIS
  • 5.3.1. MARKET IMPACT ANALYSIS
  • 5.3.2. REGIONAL IMPACT
  • 5.3.3. OPPORTUNITY AND THREAT ANALYSIS

6. POLYETHYLENE GLYCOL MARKET, BY GRADE (USD BILLION)

• 6.1. PHARMACEUTICAL GRADE
• 6.2. INDUSTRIAL GRADE
• 6.3. COSMETIC GRADE
• 6.4. FOOD GRADE

7. POLYETHYLENE GLYCOL MARKET, BY APPLICATION (USD BILLION)

• 7.1. PHARMACEUTICALS
• 7.2. COSMETICS AND PERSONAL CARE
• 7.3. FOOD AND BEVERAGES
• 7.4. INDUSTRIAL SOLVENTS
• 7.5. TEXTILE FINISHING

8. POLYETHYLENE GLYCOL MARKET, BY MOLECULAR WEIGHT (USD BILLION)

• 8.1. 200-400 G/MOL
• 8.2. 400-600 G/MOL
• 8.3. 600-1000 G/MOL
• 8.4. 1000-2000 G/MOL
• 8.5. ABOVE 2000 G/MOL

9. POLYETHYLENE GLYCOL MARKET, BY SOURCE (USD BILLION)

• 9.1. ETHYLENE OXIDE
• 9.2. ETHYLENE DICHLORIDE
• 9.3. ETHYLENE GLYCOL

10. POLYETHYLENE GLYCOL MARKET, BY END-USE INDUSTRY (USD BILLION)

• 10.1. MEDICAL DEVICE
• 10.2. PHARMACEUTICAL PACKAGING
• 10.3. LUBRICANT ADDITIVE
• 10.4. PAPER COATING

11. POLYETHYLENE GLYCOL MARKET, BY REGIONAL (USD BILLION)

• 11.1. NORTH AMERICA
  • 11.1.1. US
  • 11.1.2. CANADA
• 11.2. EUROPE
  • 11.2.1. GERMANY
  • 11.2.2. UK
  • 11.2.3. FRANCE
  • 11.2.4. RUSSIA
  • 11.2.5. ITALY
  • 11.2.6. SPAIN
  • 11.2.7. REST OF EUROPE
• 11.3. APAC
  • 11.3.1. CHINA
  • 11.3.2. INDIA
  • 11.3.3. JAPAN
  • 11.3.4. SOUTH KOREA
  • 11.3.5. MALAYSIA
  • 11.3.6. THAILAND
  • 11.3.7. INDONESIA
  • 11.3.8. REST OF APAC
• 11.4. SOUTH AMERICA
  • 11.4.1. BRAZIL
  • 11.4.2. MEXICO
  • 11.4.3. ARGENTINA
  • 11.4.4. REST OF SOUTH AMERICA
• 11.5. MEA
  • 11.5.1. GCC COUNTRIES
  • 11.5.2. SOUTH AFRICA
  • 11.5.3. REST OF MEA

12. COMPETITIVE LANDSCAPE

• 12.1. OVERVIEW
• 12.2. COMPETITIVE ANALYSIS
• 12.3. MARKET SHARE ANALYSIS
• 12.4. MAJOR GROWTH STRATEGY IN THE POLYETHYLENE GLYCOL MARKET
• 12.5. COMPETITIVE BENCHMARKING
• 12.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE POLYETHYLENE GLYCOL MARKET
• 12.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
  • 12.7.1. NEW PRODUCT LAUNCH/SERVICE DEPLOYMENT
  • 12.7.2. MERGER & ACQUISITIONS
  • 12.7.3. JOINT VENTURES
• 12.8. MAJOR PLAYERS FINANCIAL MATRIX
  • 12.8.1. SALES AND OPERATING INCOME
  • 12.8.2. MAJOR PLAYERS R&D EXPENDITURE.

13. COMPANY PROFILES

• 13.1. SABIC
  • 13.1.1. FINANCIAL OVERVIEW
  • 13.1.2. PRODUCTS OFFERED
  • 13.1.3. KEY DEVELOPMENTS
  • 13.1.4. SWOT ANALYSIS
  • 13.1.5. KEY STRATEGIES
• 13.2. SINOPEC GROUP
  • 13.2.1. FINANCIAL OVERVIEW
  • 13.2.2. PRODUCTS OFFERED
  • 13.2.3. KEY DEVELOPMENTS
  • 13.2.4. SWOT ANALYSIS
  • 13.2.5. KEY STRATEGIES
• 13.3. BRASKEM
  • 13.3.1. FINANCIAL OVERVIEW
  • 13.3.2. PRODUCTS OFFERED
  • 13.3.3. KEY DEVELOPMENTS
  • 13.3.4. SWOT ANALYSIS
  • 13.3.5. KEY STRATEGIES
• 13.4. CELANESE CORPORATION
  • 13.4.1. FINANCIAL OVERVIEW
  • 13.4.2. PRODUCTS OFFERED
  • 13.4.3. KEY DEVELOPMENTS
  • 13.4.4. SWOT ANALYSIS
  • 13.4.5. KEY STRATEGIES
• 13.5. CHINA NATIONAL CHEMICAL CORPORATION
  • 13.5.1. FINANCIAL OVERVIEW
  • 13.5.2. PRODUCTS OFFERED
  • 13.5.3. KEY DEVELOPMENTS
  • 13.5.4. SWOT ANALYSIS
  • 13.5.5. KEY STRATEGIES
• 13.6. MITSUBISHI CHEMICAL HOLDINGS CORPORATION
  • 13.6.1. FINANCIAL OVERVIEW
  • 13.6.2. PRODUCTS OFFERED
  • 13.6.3. KEY DEVELOPMENTS
  • 13.6.4. SWOT ANALYSIS
  • 13.6.5. KEY STRATEGIES
• 13.7. EXXONMOBIL
  • 13.7.1. FINANCIAL OVERVIEW
  • 13.7.2. PRODUCTS OFFERED
  • 13.7.3. KEY DEVELOPMENTS
  • 13.7.4. SWOT ANALYSIS
  • 13.7.5. KEY STRATEGIES
• 13.8. LYONDELLBASELL INDUSTRIES HOLDINGS B.V.
  • 13.8.1. FINANCIAL OVERVIEW
  • 13.8.2. PRODUCTS OFFERED
  • 13.8.3. KEY DEVELOPMENTS
  • 13.8.4. SWOT ANALYSIS
  • 13.8.5. KEY STRATEGIES
• 13.9. LG CHEM
  • 13.9.1. FINANCIAL OVERVIEW
  • 13.9.2. PRODUCTS OFFERED
  • 13.9.3. KEY DEVELOPMENTS
  • 13.9.4. SWOT ANALYSIS
  • 13.9.5. KEY STRATEGIES
• 13.10. FORMOSA PLASTICS CORPORATION
  • 13.10.1. FINANCIAL OVERVIEW
  • 13.10.2. PRODUCTS OFFERED
  • 13.10.3. KEY DEVELOPMENTS
  • 13.10.4. SWOT ANALYSIS
  • 13.10.5. KEY STRATEGIES
• 13.11. HUNTSMAN CORPORATION
  • 13.11.1. FINANCIAL OVERVIEW
  • 13.11.2. PRODUCTS OFFERED
  • 13.11.3. KEY DEVELOPMENTS
  • 13.11.4. SWOT ANALYSIS
  • 13.11.5. KEY STRATEGIES
• 13.12. INEOS GROUP LIMITED
  • 13.12.1. FINANCIAL OVERVIEW
  • 13.12.2. PRODUCTS OFFERED
  • 13.12.3. KEY DEVELOPMENTS
  • 13.12.4. SWOT ANALYSIS
  • 13.12.5. KEY STRATEGIES
• 13.13. DOW CHEMICAL COMPANY
  • 13.13.1. FINANCIAL OVERVIEW
  • 13.13.2. PRODUCTS OFFERED
  • 13.13.3. KEY DEVELOPMENTS
  • 13.13.4. SWOT ANALYSIS
  • 13.13.5. KEY STRATEGIES
• 13.14. MITSUBISHI CHEMICAL CORPORATION
  • 13.14.1. FINANCIAL OVERVIEW
  • 13.14.2. PRODUCTS OFFERED
  • 13.14.3. KEY DEVELOPMENTS
  • 13.14.4. SWOT ANALYSIS
  • 13.14.5. KEY STRATEGIES
• 13.15. BASF
  • 13.15.1. FINANCIAL OVERVIEW
  • 13.15.2. PRODUCTS OFFERED
  • 13.15.3. KEY DEVELOPMENTS
  • 13.15.4. SWOT ANALYSIS
  • 13.15.5. KEY STRATEGIES

14. APPENDIX

• 14.1. REFERENCES
• 14.2. RELATED REPORTS